Please assess the completion status of the following clinical trial:

Trial Title: The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Singleton intrauterine pregnancy ≥20 weeks and ≤35 weeks gestational age~* Chief complaint of minor maternal trauma including motor vehicle accident, patient fall or assault with absence of maternal conditions outlined in exclusion criteria~Exclusion Criteria:~* Maternal shock~* Unstable vital signs~* Altered sensorium~* Head injury resulting in coma~* signs or symptoms of intraperitoneal bleeding~* Emergency laparotomy for fetal or maternal indications~* Bone fractures~* History of previous abruptio placenta~* Known or suspected placenta previa~* Rupture of membranes~* Multiple gestation~* Advanced cervical dilatation ≥3cm~* Non-reassuring fetal status requiring intervention~* Vaginal bleeding on presentation~* History of intercourse and/or digital vaginal exam and/or vaginal ultrasound ≤24 hours prior to presentation~* Illicit drug use

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).